(0.48%) 5 246.68 points
(0.32%) 39 558 points
(0.75%) 16 511 points
(0.74%) $78.60
(-0.26%) $2.34
(0.11%) $2 362.60
(0.38%) $28.81
(1.84%) $1 063.80
(0.01%) $0.924
(0.03%) $10.80
(0.00%) $0.794
(0.02%) $91.34
Quarter results tomorrow
(bmo 2024-05-16)
Expected move: +/- 3.40%
-0.52% INR 5 183.20
Live Chart Being Loaded With Signals
Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally...
Stats | |
---|---|
Today's Volume | 290 117 |
Average Volume | 221 407 |
Market Cap | 619.73B |
EPS | INR49.76 ( 2024-02-09 ) |
Next earnings date | ( INR0 ) 2024-05-16 |
Last Dividend | INR10.00 ( 2023-08-09 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 39.32 |
ATR14 | INR8.28 (0.16%) |
Volume Correlation
Alkem Laboratories Correlation
10 Most Positive Correlations | |
---|---|
MASPTOP50.NS | 0.902 |
MAFANG.NS | 0.885 |
BAJAJ-AUTO.NS | 0.881 |
HARIOMPIPE.NS | 0.876 |
MON100.NS | 0.869 |
SETF10GILT.NS | 0.868 |
DATAPATTNS.NS | 0.868 |
MANINDS.NS | 0.865 |
MOGSEC.NS | 0.862 |
GTNTEX.NS | 0.861 |
10 Most Negative Correlations | |
---|---|
MOHOTAIND.NS | -0.877 |
ROLTA.NS | -0.865 |
SECURKLOUD.NS | -0.864 |
SUMICHEM.NS | -0.861 |
RUSHIL.NS | -0.852 |
CLNINDIA.NS | -0.849 |
BAFNAPH.NS | -0.848 |
LICI.NS | -0.847 |
DPSCLTD.NS | -0.846 |
EASTSILK.NS | -0.841 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Alkem Laboratories Correlation - Currency/Commodity
Alkem Laboratories Financials
Annual | 2022 |
Revenue: | INR115.99B |
Gross Profit: | INR66.92B (57.70 %) |
EPS: | INR82.31 |
FY | 2022 |
Revenue: | INR115.99B |
Gross Profit: | INR66.92B (57.70 %) |
EPS: | INR82.31 |
FY | 2022 |
Revenue: | INR105.12B |
Gross Profit: | INR62.29B (59.25 %) |
EPS: | INR137.63 |
FY | 2021 |
Revenue: | INR87.47B |
Gross Profit: | INR51.61B (59.00 %) |
EPS: | INR132.57 |
Financial Reports:
No articles found.
Alkem Laboratories Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR4.00 (N/A) |
INR0 (N/A) |
INR25.00 (N/A) |
INR0 (N/A) |
INR10.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR9.70 | 2016-03-18 |
Last Dividend | INR10.00 | 2023-08-09 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | INR177.70 | -- |
Avg. Dividend % Per Year | 0.71% | -- |
Score | 2.84 | -- |
Div. Sustainability Score | 3.90 | |
Div.Growth Potential Score | 5.48 | |
Div. Directional Score | 4.69 | -- |
Year | Amount | Yield |
---|---|---|
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR13.00 | 0.65% |
2019 | INR16.00 | 0.83% |
2020 | INR25.00 | 1.20% |
2021 | INR30.00 | 1.02% |
2022 | INR34.00 | 0.93% |
2023 | INR35.00 | 1.17% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TATAPOWER.NS | Dividend Junior | 2023-06-07 | Annually | 29 | 0.85% | |
NOCIL.NS | Dividend Junior | 2023-07-24 | Annually | 19 | 1.11% | |
INDIGOPNTS.NS | Dividend Junior | 2023-07-28 | Annually | 3 | 0.11% | |
CLEAN.NS | Dividend Junior | 2023-08-03 | Semi-Annually | 3 | 0.13% | |
SBC.NS | Dividend Junior | 2023-09-18 | Insufficient data to determine frequency | 2 | 0.11% | |
MAHINDCIE.NS | Dividend Junior | 2023-06-02 | Annually | 3 | 0.66% | |
GMBREW.NS | Dividend Junior | 2023-05-16 | Annually | 22 | 0.55% | |
ASTRAL.NS | Dividend Junior | 2023-08-04 | Semi-Annually | 17 | 0.10% | |
TORNTPHARM.NS | Dividend Junior | 2023-06-23 | Annually | 22 | 0.85% | |
PFS.NS | Dividend Junior | 2023-09-05 | Sporadic | 14 | 1.84% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.125 | 1.500 | 7.51 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.163 | 1.500 | 9.30 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 18.58 | 1.000 | 4.23 | 4.23 | [3 - 30] |
operatingCashFlowPerShareTTM | 49.21 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 49.21 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.597 | 1.000 | 3.38 | 3.38 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.168 | 1.000 | 8.63 | 8.63 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.90 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 39.22 | 1.000 | 6.14 | 0 | [1 - 100] |
returnOnEquityTTM | 0.163 | 2.50 | 9.55 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 49.21 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.872 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 49.21 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 10.28 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0466 | 1.000 | -1.336 | 0 | [0.1 - 0.5] |
Total Score | 5.48 |
Alkem Laboratories
Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, oncology, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. It also provides pregnancy detection kits and condoms. The company was incorporated in 1973 and is headquartered in Mumbai, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators